Completed PHASE2 INTERVENTIONAL 2-arm NCT02851108

Methylene Blue Against Falciparum Malaria in Burkina Faso (BlueACTn)

Safety of Artesunate-amodiaquine Combined With Methylene Blue or Primaquine for Falciparum Malaria Treatment in African Children: A Randomised Controlled Trial

Sponsor: Centre de Recherche en Sante de Nouna, Burkina Faso

Conditions Malaria, Falciparum

Interventions Methylene Blue Primaquine

Updated 9 times since 2017 Last updated: Mar 11, 2020 Started: Oct 31, 2016 Primary completion: Dec 31, 2016 Completion: Feb 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Malaria, Falciparum, this trial is completed. The trial is conducted by Centre de Recherche en Sante de Nouna, Burkina Faso and has accumulated 9 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Apr 2020 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Apr 2020 [monthly]

Completed PHASE2
Jun 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2017 — Jun 2017 [monthly]

Recruiting PHASE2

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre de Recherche en Sante de Nouna, Burkina Faso
Heidelberg University

Data source: Heidelberg University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nouna, Burkina Faso